Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 7/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 7/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.39 |
| ▸ | NEK2 | P51955 | 1/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.39 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.39 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.39 |
| ▸ | NSD2 | O96028 | 2/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2,3,5-Triiodobenzoic Acid SCHEMBL5500551 | 0.84 | MCL1 (0.38) | ALDH1A1L3MBTL1KEAP1NFE2L2POLB | |
| Dansylsarcosine SCHEMBL30586115 | 0.80 | L3MBTL1 (0.61) | ALDH1A1L3MBTL1KEAP1NFE2L2MCL1 | |
| Dansylsarcosine SCHEMBL39162 | 0.80 | L3MBTL1 (0.61) | ALDH1A1L3MBTL1KEAP1NFE2L2MCL1 | |
| SCHEMBL11888757 | 0.79 | KEAP1 (0.66) | ALDH1A1L3MBTL1KEAP1NFE2L2POLB | |
| SCHEMBL9276192 | 0.78 | CHEK1 (0.48) | ALDH1A1L3MBTL1POLBTTRCHEK1 | |
| SCHEMBL29228941 | 0.77 | TTR (0.41) | L3MBTL1KEAP1NFE2L2TTRCHEK1 | |
| SCHEMBL11687795 | 0.75 | KMT2A (0.38) | ALDH1A1L3MBTL1HPGDTTRKDM4E | |
| SCHEMBL11242851 | 0.74 | POLB (0.56) | ALDH1A1L3MBTL1KEAP1NFE2L2POLB | |
| Hydrochloric Acid SCHEMBL4444966 | 0.73 | NSD2 (0.56) | ALDH1A1L3MBTL1POLBHPGDTTR | |
| SCHEMBL6767980 | 0.73 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1KEAP1NFE2L2POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3731 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3612842-B1 | METHODS FOR DETERMINING THE RELATIVE BINDING CAPACITY OF ALBUMIN | FRAUNHOFER GES FORSCHUNG (DE) | 2025-11-26 | — | — | EP | claimed |
| CN-119993473-A | System and method for predicting long-term prognosis of liver disease patient | 上海交通大学医学院附属瑞金医院 | 2025-05-13 | — | — | CN | claimed |
| EP-3884280-B1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | INST NAT SANTE RECH MED (FR) | 2024-01-17 | — | — | EP | claimed |
| US-20220018852-A1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE DE LIMOGES (FR) | 2022-01-20 | — | — | US | claimed |
| EP-3884280-A1 | METHODS AND KITS FOR DETECTING LIVER DYSFUNCTION IN A SUBJECT | Institut National de la Santé et de la Recherche Médicale (INSERM) (FR) | 2021-09-29 | — | — | EP | claimed |
| US-8476081-B2 | Assay for evaluating affinity and specificity of ligand-albumin binding | JANSSEN PHARMACEUTICA NV (BE) | 2013-07-02 | — | — | US | claimed |
| US-20110124120-A1 | ASSAY FOR EVALUATING AFFINITY AND SPECIFICITY OF LIGAND-ALBUMIN BINDING | JANSSEN PHARMACEUTICA N.V. (BE) | 2011-05-26 | — | — | US | claimed |
| US-20100240602-A1 | METHODS AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | BURKE THOMAS G | 2010-09-23 | — | — | US | claimed |
| EP-1315973-B1 | INDIRECT METHOD FOR THE QUANTITATIVE ANALYSIS OF THE BINDING CAPACITY PRESENT IN AN AQUEOUS PROTEIN SOLUTION | GAMBRO LUNDIA AB (SE) | 2009-07-29 | — | — | EP | claimed |
| EP-1372571-A4 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS (US) | 2006-06-07 | — | — | EP | claimed |
| JP-2003501487-A | — | — | 2003-01-14 | — | — | JP | claimed |
| JP-2002544523-A | — | — | 2002-12-24 | — | — | JP | claimed |
| US-20020193318-A1 | Methods and compositions for optimizing blood and tissue stability of camptothecin and other albumin-binding therapeutic compounds | NEW CENTURY PHARMACEUTICALS, INC. | 2002-12-19 | — | — | US | claimed |
| WO-2002074246-A2 | METHOD AND COMPOSITIONS FOR OPTIMIZING BLOOD AND TISSUE STABILITY OF CAMPTOTHECIN AND OTHER ALBUMIN-BINDING THERAPEUTIC COMPOUNDS | NEW CENTURY PHARMACEUTICALS, INC. (US) | 2002-09-26 | — | — | WO | claimed |
| EP-1185305-A1 | LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2002-03-13 | — | — | EP | claimed |
| EP-1180244-A2 | HIGH TROUGHPUT ASSAY SYSTEMS AND METHODS | Caliper Technologies Corporation (US) | 2002-02-20 | — | — | EP | claimed |
| WO-2000076554-A1 | LIGAND-CONJUGATED OLIGOMERIC COMPOUNDS | ISIS PHARMACEUTICALS, INC. (US) | 2000-12-21 | — | — | WO | claimed |
| WO-2000070353-A2 | HIGH THROUGHPUT ASSAY SYSTEMS AND METHODS | CALIPER TECHNOLOGIES CORP. (US) | 2000-11-23 | — | — | WO | claimed |
| US-5541633-A | Ink jet printing of concealed images on carbonless paper | XEROX CORPORATION (US) | 1996-07-30 | — | — | US | claimed |
| US-5286286-A | Containing diethylene glycol monobutyl ether, glycerol, and a dansyl or porphyrin chromophores | XEROX CORPORATION (US) | 1994-02-15 | — | — | US | claimed |